Executive Summary
Across 50 MCA-tracked corporate governance filings for May 13, 2026, the dominant theme is FY26/Q4 results approvals and upcoming board meetings (28/50 filings), signaling peak earnings season with 12 companies reporting revenue growth averaging +25% YoY (e.g., Smartlink +29.4%, Paras Defence +24.8%) but mixed PAT trends (6 positive surges like Smartlink +421%, 4 declines like Tube Investments -36.2% YoY).
Capital allocation favors dividends in 10 companies (e.g., Sharda Cropchem ₹9/share, Premco ₹2/share), indicating shareholder returns amid stable governance via 8 new appointments/re-appointments (e.g., Arati Naik as Executive Director). Scheduled events cluster in late May (18 meetings May 16-30) and AGMs June-August, building a catalyst calendar; sentiment skews positive/neutral (38/50), with minor risks from delays (Mysore Paper 'sick' status) and reschedules (5 cases). No insider trading or M&A details prominent, but warrant allotments (Clio, Velox) signal growth funding. Portfolio implication: overweight dividend payers with strong YoY growth; monitor May results for guidance/upside surprises amid governance stability.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Corporate governance
Tracking the trend? Catch up on the prior India Corporate Governance MCA ROC Filings digest from May 12, 2026.
Investment Signals (12)
- Smartlink Holdings ↓ (BULLISH)▲
Revenue +29.4% YoY to ₹12,546.81 L, PAT +421% YoY to ₹1,321.99 L, final dividend ₹2/share, record date July 10, 2026
- Premco Global ↓ (BULLISH)▲
Unmodified audit opinion, final dividend ₹2/share (20% payout), new Company Secretary appointed, Q4/FY26 results approved
- Paras Defence ↓ (BULLISH)▲
Standalone revenue +24.8% YoY to ₹41,654 L FY26 (+39.3% YoY Q4), final dividend ₹1/share, internal/cost auditors re-appointed
- Sharda Cropchem ↓ (BULLISH)▲
Clean audit opinion, final dividend ₹9/share, consolidated FY26 revenue ₹2,80,239 L from 26 subsidiaries
- A-1 Limited ↓ (BULLISH)▲
Revenue +3.4% YoY to ₹34,290.92 L FY26 (+32.6% Q4), PAT +64.1% YoY to ₹599.21 L on lower expenses/depreciation
- Texmaco Infrastructure ↓ (BULLISH)▲
Unmodified audit, dividend 15% (₹0.15/share), FY26/Q4 results approved post-May 13 board meeting
- Black Rose Industries ↓ (BULLISH)▲
Unmodified audit, final dividend ₹1.25/share (125% payout), key executives re-appointed/re-designated
- Flora Corporation ↓ (BULLISH)▲
Unmodified audit opinion, secretarial auditor appointed, non-applicability of RPT reporting due to small size
- GlaxoSmithKline Pharma ↓ (BULLISH)▲
FY26 revenue +1.9% YoY to ₹382,167 L, PAT +11.7% YoY to ₹103,598 L, dividend ₹57/share, record date May 29
-
Revenue +8.4% YoY FY26 to ₹8,556.35 Cr (+16.4% Q4), but PAT -36.2% YoY; Engineering segment +21.8% Q4 [MIXED/BEARISH LEAN]
- Perfectpac ↓ (BEARISH)▲
FY26 revenue flat +0.24% YoY to ₹11,373.48 L, PAT -0.08% YoY, Q4 revenue -6.21% YoY despite +12.89% profit
-
FY26/Q4 consolidated net loss despite unmodified audit, but dividend ₹3/share proposed, AGM Aug 7 [MIXED/BEARISH LEAN]
Risk Flags (9)
- Tube Investments (Profit Decline) [HIGH RISK]▼
PAT -36.2% YoY FY26 to ₹827.35 Cr (-65.2% Q4), PBT -28.9% YoY, exceptional losses -₹22.75 Cr, segment results mixed
- Mysore Paper Mills (Delay/Governance) [HIGH RISK]▼
Q4 FY26 results delayed due to 'sick' BIFR status since 2014-15, operations ceased 2015-16, CFO death during Covid
- Perfectpac (Stagnation) [MEDIUM RISK]▼
FY26 revenue +0.24% YoY flat, Q4 -6.21% YoY, Q3 loss ₹3.56 L, exceptional expense ₹12 L on labour codes
- S V Global Mill (Reschedule) [LOW RISK]▼
Board meeting rescheduled May 18 to May 25 for FY26 results, trading window extended
- Standard Capital Markets (Cancellation) [MEDIUM RISK]▼
Board meeting cancelled twice (May 9/13) due to audit delays, items deferred
- VLS Finance (Reschedule) [LOW RISK]▼
Board meeting rescheduled May 18 to May 26 for FY26 results/dividend due to unavoidable circumstances
- Yashraj Containeurs (Insolvency) [HIGH RISK]▼
RP Committee meeting postponed to May 25, under CIRP, trading window closed
- Clio Infotech (Dilution) [MEDIUM RISK]▼
2.17 Cr warrants allotted to non-promoter at ₹25/warrant (₹5.44 Cr upfront), potential 18-month dilution
- Tube Investments (EPS Drop) [MEDIUM RISK]▼
Basic EPS FY26 ₹42.76 vs ₹67.03 FY25 (-36% YoY), capital employed +12.9% YoY
Opportunities (10)
- Smartlink Holdings/Dividend Catalyst↓ (OPPORTUNITY)◆
PAT +421% YoY, dividend ₹2/share record date July 10, 2026; board approved Arati Naik as Exec Director Apr 2027
- Paras Defence/Growth↓ (OPPORTUNITY)◆
Revenue +24.8% YoY FY26, +39.3% Q4 YoY; dividend ₹1/share, trading window reopens post-results
- Sharda Cropchem/Subsidiary Strength↓ (OPPORTUNITY)◆
26 subsidiaries contribute ₹2.8 Cr revenue FY26, dividend ₹9/share, clean audits
- Clio Infotech/Warrant Funding↓ (OPPORTUNITY)◆
2.17 Cr warrants to Falcon Peak Fund ₹21.75 Cr potential, 25% upfront ₹5.44 Cr, shareholder approval via postal ballot ends June 12
- Velox Shipping/Warrant Allotment↓ (OPPORTUNITY)◆
2.83 Cr warrants at ₹12 (₹8.5 Cr upfront) to non-promoters, board approval May 16
- Zydus Lifesciences/Buyback↓ (OPPORTUNITY)◆
Board to consider equity buyback May 19, trading window closes until May 21
- GlaxoSmithKline/Dividend Yield↓ (OPPORTUNITY)◆
Dividend ₹57/share (record May 29), FY26 PAT +11.7% YoY, AGM June 30
- Texmaco Infra/Dividend Payout↓ (OPPORTUNITY)◆
15% dividend (₹0.15/share), unmodified audits for FY26, payment within 30 days post-AGM
- Premco Global/Governance Stability↓ (OPPORTUNITY)◆
New CS appointed, dividend ₹2/share, revised filing confirms clean Q4/FY26 results
- Gennex Labs/Director Approval (OPPORTUNITY)◆
Independent Woman Director regularized with 99.9997% approval at EGM May 12
Sector Themes (6)
- Dividend Momentum (10/50 Cos) (POSITIVE)◆
20% of filings announce final dividends (avg ₹5-9/share, e.g., Sharda ₹9, Glaxo ₹57), signaling capital returns amid FY26 earnings; implies healthy cash flows, buy for yield pre-record dates
- Revenue Growth vs PAT Volatility (MIXED)◆
12 cos report avg +25% YoY revenue (Smartlink +29%, Paras +25%), but 4 show PAT declines avg -30% (Tube -36%); growth intact but expense pressures; favour revenue outperformers
- Board Meeting Cluster (May 16-30) (CATALYST DRIVEN)◆
25+ meetings for FY26 results/dividends (e.g., SERA May 21, Bodal May 21), trading windows closed; pre-empt upside surprises in smallcaps like Clio/Sigma
- Governance Appointments/Stability (8/50) (BULLISH)◆
New directors/CS/auditors (Arati Naik, Jay Sonavane, Marico's Girish Paranjpe postal ballot); reduces MCA disqualification risks, positive for compliance-heavy smallcaps
- Audit Cleanliness (15/50) (POSITIVE)◆
Unmodified/unqualified opinions dominant (e.g., Premco, Sharda, Texmaco); contrasts Mysore delay; sector-wide trust boost for investors
- Delay/Reschedule Pattern (7/50) (CAUTION)◆
14% filings delayed/cancelled (Mysore sick, VLS/SV Global reschedules); watch 'distressed' like Yashraj CIRP for turnaround/avoid
Watch List (8)
-
FY26 results approval May 21; neutral sentiment, potential dividend [May 21, 2026]
-
Audited FY26 results/dividend/AGM date May 19 [May 19, 2026]
-
FY26 results/internal auditor appt May 19, trading window reopens post [May 19, 2026]
-
Standalone/consolidated FY26 + dividend May 21 [May 21, 2026]
-
FY26 results/dividend May 25 [May 25, 2026]
-
Independent Director Girish Paranjpe approval, e-voting ends June 13, results June 16 [June 13-16, 2026]
-
Dividend ₹2/share, buy before July 10 [July 10, 2026]
-
FY26 loss details + dividend ₹3/share approval, record July 24 [Aug 7, 2026]
Filing Analyses
(50)
13-05-2026
The Board of Smartlink Holdings Limited approved audited standalone financial results for FY26 (year ended March 31, 2026), showing revenue from operations up 29.4% YoY to ₹12,546.81 L and profit after tax surging 421% YoY to ₹1,321.99 L, driven by strong Q4 performance with revenue at ₹5,297.36 L (up 80% YoY). The Board recommended a final dividend of ₹2.00 per equity share (100% on face value of ₹2) and set the record date as July 10, 2026. Additionally, approvals were made for appointing Ms. Arati Naik as Executive Director and re-appointing auditors, with unmodified audit opinions issued.
- · Record date for dividend: Friday, July 10, 2026.
- · Appointment of Ms. Arati Naik as Wholetime Executive Director for 5 years effective April 01, 2027.
- · Re-appointment of M/s Marathe Rao & Swarup as internal auditors for FY 2026-27.
- · Appointment of M S K A & Associates LLP as Statutory Auditors for 5 years subject to AGM approval.
- · Statutory Auditors issued unmodified (unqualified) opinions on standalone and consolidated financial statements.
- · Q3 FY26 (Dec 31, 2025) reported PAT loss of ₹81.81 L.
13-05-2026
Flora Corporation Limited's Board of Directors, in a meeting held on May 13, 2026, approved the audited standalone financial results for the quarter and year ended March 31, 2026, along with the auditors' report issuing an unmodified opinion. The Board also appointed a Secretarial Auditor for FY 2026-27. The company disclosed non-applicability of related party transaction reporting under Regulation 23(9) due to paid-up equity share capital of ₹8,73,38,750 and net worth of ₹5,13,50,499, both below SEBI thresholds.
- · Scrip Code: 540267; ISIN: INE318U01016
- · CIN: L01403TG1988PLC154725
- · Board meeting held from 01:00 P.M. to 02:00 P.M. at registered office
- · Statutory Auditors: M/s Sapna Toshniwal & Co. (Firm Reg No: 0126385)
13-05-2026
SERA INVESTMENTS & FINANCE INDIA LIMITED has scheduled a Board of Directors meeting on May 21, 2026, at its registered office to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, in compliance with Regulation 33 of SEBI LODR. The notice is issued under Regulation 29(1)(a) of SEBI LODR and addresses BSE Ltd. (Scrip Code: 512399). The meeting may also transact any other business with the Chair's permission.
- · Company CIN: L51900GJ1985PLC110976
- · Scrip Code: 512399
- · Registered Office: 306 & 307, Ashirwad Paras 1, Opp Andaz Party Plot, Makarba, SG Highway, Ahmedabad, Gujarat - 380051
13-05-2026
Sagar Systech Limited's Board of Directors, at its meeting on May 13, 2026, approved the audited financial results and statements for the quarter and year ended March 31, 2026, along with an unmodified auditor’s opinion from M/s. Shah, Shah & Shah. The board also approved the notice for the 42nd Annual General Meeting scheduled for August 12, 2026, the Directors' Report for FY 2026, closure of the Register of Members, appointment of a secretarial auditor for FY 2026-27, and M/s. V. V. Chakradeo & Co. as scrutinizer for voting. No specific financial metrics were disclosed in the announcement.
- · 42nd AGM venue: 301-302, Sagar Avenue, S. V Road, Andheri (West), Mumbai-400058, Maharashtra
- · Board meeting timings: commenced at 1:30 p.m. and concluded at 2:00 p.m. on May 13, 2026
- · Enclosures: Statement of Assets and Liability as on March 31, 2026; Audited Financial Results; Cash flow statement; Declaration under Regulation 33(3)(d); Auditor Report
13-05-2026
Premco Global Ltd. submitted a revised outcome of its Board meeting held on May 11, 2026, correcting an administrative error where the digitally signed audit report was not visible in the prior filing. The Board approved audited standalone and consolidated financial results and financial statements for the quarter and financial year ended March 31, 2026, receiving an unqualified and unmodified audit opinion from S.P. Jain & Associates. The Board also recommended a final dividend of ₹2 per equity share of ₹10 each, subject to shareholder approval, and appointed CS Jay Narendra Sonavane as Company Secretary & Compliance Officer effective May 11, 2026.
- · Re-appointment of Internal Auditor (M/s Chaturvedi and Partners) deferred to next Board meeting.
- · Board meeting commenced at 03:45 P.M. and concluded at 4:45 P.M. on May 11, 2026.
- · Record date for dividend to be intimated to stock exchanges in due course.
13-05-2026
Ceenik Exports (India) Ltd. has intimated BSE Limited that a Board of Directors meeting is scheduled for Friday, May 22, 2026, to consider and approve the standalone audited financial results for the year ended March 31, 2026, along with the auditors' report. The company's Code of Conduct for prevention of Insider Trading has closed the trading window for equity shares from April 1, 2026, until 48 hours after communication of the financial results to the stock exchange.
- · Security ID: CEENIK / Security Code: 531119 / ISIN: INE418D01010
- · Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
13-05-2026
Clio Infotech Ltd.'s Board approved the allotment of 2,17,50,000 convertible warrants to non-promoter Falcon Peak Fund (CEIC) Ltd. for ₹5,43,75,000 cash consideration (25% upfront), each convertible into one ₹10 face value equity share within 18 months upon payment of balance 75%. The Board also ratified the prior shareholder resolution for the warrant issue due to price re-computation, authorized loans/guarantees/investments up to ₹100 Crores under Section 186 subject to shareholder approval, appointed Ms. Shubhangi Agarwal as scrutinizer, and approved issuing a postal ballot notice.
- · Warrants allotted per SEBI (ICDR) Regulations, 2018 Chapter V, with price re-computed accordingly.
- · Shareholder resolution ratified from AGM on September 12, 2025.
- · Board meeting held May 13, 2026, from 1:30 P.M. to 2:00 P.M. at registered office.
- · New equity shares to rank pari-passu with existing shares.
13-05-2026
Tube Investments of India Limited reported standalone revenue from operations of ₹8,556.35 Cr for FY26, up 8.4% YoY from ₹7,892.53 Cr, with Q4 FY26 revenue at ₹2,278.57 Cr, up 16.4% YoY from ₹1,957.25 Cr, driven by strong Engineering segment growth of 21.8% YoY. However, profit after tax declined sharply 36.2% YoY to ₹827.35 Cr for FY26 from ₹1,296.66 Cr and 65.2% in Q4 to ₹283.52 Cr from ₹813.65 Cr, due to higher expenses and lower profit before exceptional items. Segment results were mixed, with Metal Formed Products down 10.9% and Mobility flat at -2.1% in Q4, while Others declined 6.5% YoY for the year.
- · Basic EPS FY26: ₹42.76 (vs ₹67.03 FY25)
- · Exceptional items FY26: -₹22.75 Cr
- · Total capital employed FY26: ₹5,988.63 Cr (up 12.9% YoY)
- · Investments in subsidiaries, JVs and associates: ₹3,499.02 Cr
- · The Q4 FY26 figures are balancing figures between audited FY and unaudited YTD Q3
13-05-2026
Tube Investments of India Limited reported audited standalone financial results for Q4 FY26 and FY26 ended March 31, 2026, with total revenue from operations growing 16.4% YoY to ₹2,278.57 Cr in Q4 and 8.4% YoY to ₹8,556.35 Cr for FY26. However, profit before tax declined sharply 59.4% YoY to ₹357.21 Cr in Q4 and 28.9% YoY to ₹1,082.80 Cr for FY26, while PAT fell 65.2% YoY to ₹283.52 Cr in Q4 and 36.2% YoY to ₹827.35 Cr for FY26, impacted by exceptional losses and lower segment results despite a ₹569 Cr fair value gain on CCPS. Segment revenue grew across Engineering (+21.9% YoY), Metal Formed Products (+4.3% YoY), and Mobility (+14.9% YoY) in Q4, but segment results were mixed with declines in Engineering and Metal Formed Products.
- · Basic EPS FY26: ₹42.76 (down from ₹67.03 in FY25)
- · Paid-up Equity Share Capital: ₹19.36 Cr
- · Total Segment Assets as at March 31, 2026: ₹7,491.09 Cr (up from ₹6,571.21 Cr as at March 31, 2025)
- · Exceptional items FY26: -₹22.75 Cr
- · Q4 FY26 QoQ Revenue growth: 5.8% from Q3 FY26
13-05-2026
DISA India Limited announced a Board of Directors meeting scheduled for May 19, 2026, to consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with recommendation of final dividend for FY 2025-26, if any. The meeting will also address fixation of the Annual General Meeting date and closure of share transfer books and register of members. No financial figures or performance metrics have been disclosed in this intimation.
13-05-2026
Sigma Solve Limited has intimated that a Board of Directors meeting is scheduled for May 19, 2026, at 10:30 a.m. IST to approve the annual audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with the auditor’s report under Regulation 33. The agenda also includes the appointment of an Internal Auditor for FY 2026-2027 and any other business with the Chairman's permission. In compliance with the insider trading code, the trading window is closed for directors, designated persons, and immediate relatives from April 1, 2026, until 48 hours after the results are public.
- · Symbol: SIGMA; Scrip Code: 543917
- · CIN: L72200GJ2010PLC060478
- · Meeting location: Registered Office, 801-803, PV Enclave, ICICI Bank Lane, Sindhubhavan Road, Ahmedabad - 380054
13-05-2026
Sharda Cropchem Limited's Board of Directors approved the audited consolidated and standalone financial results for the financial year ended March 31, 2026, accompanied by a clean audit opinion from B S R & Co. LLP with no qualifications or reservations. The Board recommended a final dividend of Rs. 9.00 per equity share of face value Rs. 10.00, subject to shareholder approval at the forthcoming Annual General Meeting. The consolidated results include financials from 26 audited subsidiaries reflecting total assets of Rs. 1,67,737 lakhs, total revenue of Rs. 2,80,239 lakhs, total net profit after tax of Rs. 21,070 lakhs, and net cash flows of Rs. 2,184 lakhs (before consolidation adjustments).
- · Statutory Auditors issued unqualified audit report; no statement on impact of audit qualifications required.
- · Two unaudited subsidiaries reported nil assets, revenue, net profit after tax, and net cash flows.
- · Board meeting held on 13 May 2026 from 01:00 pm to 2:30 pm at registered office.
- · Annual General Meeting date to be intimated in due course.
13-05-2026
Paras Defence and Space Technologies Limited's Board approved the audited standalone and consolidated financial results for the quarter and FY ended March 31, 2026, with standalone revenue from operations reaching ₹41,654 L for FY26 (up 24.8% YoY from ₹33,385 L) and ₹12,558 L for Q4 FY26 (up 39.3% YoY from ₹9,016 L and 24.6% QoQ from ₹10,083 L). The Board recommended a final dividend of ₹1 per equity share of ₹5 face value, subject to shareholder approval at the upcoming AGM. The statutory auditors, Chaturvedi & Shah LLP, issued an unmodified opinion on the results.
- · Re-appointment of M/s S M L and Co. LLP as Internal Auditor for FY 2026-27.
- · Re-appointment of M/s Dinesh Jain & Company as Cost Auditor for FY 2026-27, subject to AGM ratification.
- · Trading Window for Designated Persons reopens 48 hours after dissemination of this announcement.
- · Board meeting held on May 13, 2026, from 12:00 noon to 2:25 p.m.
- · AGM date, record date for dividend, and payment date to be communicated in due course.
13-05-2026
Modern Dairies Ltd. has notified BSE Limited of an upcoming Board of Directors meeting on May 22, 2026, at its corporate office in Chandigarh to consider and approve the Audited Financial Results for the fourth quarter and financial year ended March 31, 2026. This complies with Regulation 29 of SEBI (LODR) Regulations, 2015. The notice is also available on the company's website www.moderndairies.com.
- · Scrip Code: 519287, ISIN: INE617B01011
- · Meeting venue: SCO 98-99, Sub City Centre, Sector 34, Chandigarh - 160022
- · Reference: MDL/SECT/BSE/1003
13-05-2026
Clio Infotech Limited has issued a Postal Ballot Notice dated May 13, 2026, seeking shareholder approval via e-voting for issuing up to 2,17,50,000 convertible warrants to non-promoter Falcon Peak Fund (CEIC) LTD at ₹10 per warrant, aggregating up to ₹21,75,00,000 in cash consideration. The warrants are exercisable into equity shares within 18 months, with 25% upfront payment and 75% on conversion, superseding an earlier AGM resolution from September 2024. E-voting commences May 14, 2026, at 9:00 A.M. IST and ends June 12, 2026, at 5:00 P.M. IST, with results by June 14, 2026.
- · Cut-off date for e-voting eligibility: Friday, May 08, 2026
- · Relevant date for pricing: May 13, 2026
- · Warrants to be allotted within 15 days of shareholder approval
- · Equity shares upon conversion subject to SEBI ICDR lock-in
- · Scrutinizer: Ms. Shubhangi Agarwal (ICSI Membership No. A63219, CP No. 23802)
13-05-2026
Mysore Paper Mills Ltd. disclosed reasons for delaying submission of unaudited provisional financial results for Q4 FY2025-26 (ended March 31, 2026), originally due by May 15, 2026, citing historical accounting challenges from FY2014-15 where auditors deemed the company 'not an ongoing concern' and it was declared 'sick' by BIFR. Operations ceased in 2015-16 due to huge losses since 2009, formally closed in October 2021, with activities now limited to forest plantations; further delays arose from the sudden demise of the CFO during Covid-19 and lack of replacement. The company, assisted by external consultants M/s. Manian & Rao, plans to submit results soon after Board approval.
- · 80th AGM for FY2014-15 held on December 29, 2021, in virtual mode
- · 81st AGM for FY2015-16 held on November 29, 2025, at 12 p.m. in virtual mode
- · Statutory audit for FY2015-16 completed with 'Nil Comments Certificate' from CAG
- · BIFR sick company case No. 601/2012
- · CIN: L99999KA1936SGC000173
- · Operations stopped since 2015-16, formally closed October 2021
13-05-2026
Perfectpac Limited's Board approved audited financial results for Q4 and FY26 ended March 31, 2026, showing nearly flat revenue of ₹11,373.48 L (up 0.24% YoY) and profit of ₹314.95 L (down 0.08% YoY from ₹315.20 L), with Q4 revenue declining 6.21% YoY to ₹2,964.52 L despite a 12.89% YoY profit increase to ₹77.29 L. The company recorded an exceptional expense of ₹12 L related to New Labour Codes and recommended a dividend of Re. 1/- (50%) per equity share of Rs. 2/- face value, subject to shareholder approval. Auditor issued an unmodified opinion.
- · Q3 FY26 reported a loss of ₹3.56 L (EPS -0.05).
- · EPS for FY26 and FY25 both ₹4.73 (basic and diluted).
- · Operations relate to single reportable segment: Packaging.
13-05-2026
Crysdale Industries Limited (formerly Relson India Limited) has intimated BSE Limited of a Board of Directors meeting scheduled for May 18, 2026, to consider and approve the Audited Financial Results (both standalone and consolidated) for the quarter and year ended March 31, 2026. This notice is issued pursuant to Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015. No financial data or performance metrics are disclosed in this intimation.
- · Scrip Code: 502473
- · Scrip ID: CRYSDALE
- · ISIN: INE0SV601019
- · CIN: L51900MH1987PLC042111
- · Meeting venue: S7 - 13, 7th Floor, B wing Pinnacle Business Park, Mahakali Caves Road, MIDC, Andheri East, Chakala Midc, Mumbai - 400093, Maharashtra, India
13-05-2026
S V Global Mill Limited has rescheduled its Board of Directors meeting from May 18, 2026, to May 25, 2026, to consider and approve the Audited Standalone and Consolidated Financial Statements for the quarter and financial year ended March 31, 2026. The trading window, which commenced on April 1, 2026, will remain closed until 48 hours after the declaration of the audited financial results on May 25, 2026.
- · Earlier intimation letter dated May 8, 2026.
- · Scrip Code: 535621
- · Filing reference: SVGML/BM/Int/Q4/FY2025-26
13-05-2026
Bodal Chemicals Limited has announced that a Board of Directors meeting will be held on May 21, 2026, at the company's corporate office in Ahmedabad or via video conferencing to approve standalone and consolidated audited financial results for the financial year ended March 31, 2026. The company has closed the trading window for insiders under SEBI regulations, which will reopen 48 hours after the financial results declaration, effective May 24, 2026.
- · BSE Code: 524370; NSE Code: BODALCHEM
- · Meeting venue: “BODAL CORPORATE HOUSE”, Nr. Shilaj Circle, Off. S. P. Ring Road, Thaltej, Ahmedabad, or through Video Conferencing / Other Audio-Visual Means
13-05-2026
Tarmat Limited has intimated that a Board Meeting is scheduled for May 30, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results for the fourth quarter and financial year ended March 31, 2026. The trading window for dealing in equity shares by designated persons and their immediate relatives remains closed from April 1, 2026, until 48 hours after the declaration of results.
- · NSE Symbol: TARMAT
- · BSE Script Code: 532869
- · CIN: L45203MH1986PLC038535
- · Company Address: A. K. Vaidya Marg, Near Wageshwari Mandir, Off Film City Road, Malad (E), Mumbai - 400 097
13-05-2026
Modern Steels Limited has notified BSE Limited of an upcoming Board of Directors meeting on Friday, May 22, 2026, at its corporate office in Chandigarh, to consider and approve the Audited Financial Results for the fourth quarter and financial year ended March 31, 2026. This disclosure complies with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation is also available on the company's website.
- · Scrip Code: 513303
- · ISIN: INE001F01019
- · Corporate Office: SCO 98-99, Sub City Centre, Sector 34, Chandigarh - 160022
- · Company Website: www.modernsteels.com
- · Reference: MSL/SECT/BSE/2029
13-05-2026
GlaxoSmithKline Pharmaceuticals Limited reported consolidated revenue from operations of ₹382167 L for FY26, up 1.9% YoY from ₹374921 L but nearly flat, while profit for the year rose 11.7% to ₹103598 L supported by exceptional items credit of ₹2062 L. Total expenses declined to ₹258164 L from ₹263995 L, though Q4 revenue grew modestly 2.2% to ₹99530 L from ₹97437 L. The Board recommended a final dividend of Rs.57/- per equity share (face value Rs.10), fixed record date as May 29, 2026, and scheduled the 101st AGM for June 30, 2026.
- · Record date for dividend: Friday, 29th May 2026
- · 101st AGM date: Tuesday, 30th June 2026 via VC/AVM
- · Dividend payment on/after Wednesday, 1st July 2026
- · Company not classified as Large Corporate (no debt securities, borrowings < Rs. 1,000 Crores, no credit ratings)
- · Labour Codes impact: incremental ₹1182 L increase in employee benefits expense FY26
- · Exceptional items FY26: ₹264 L (surplus residential properties) + ₹1798 L (non-operational land)
- · Consolidated total assets: ₹432387 L (31.03.2026) vs ₹410808 L (31.03.2025)
13-05-2026
Cenlub Industries Ltd. (CIN: L67120HR1992PLC035087) has informed BSE that its Board of Directors will meet on May 29, 2026, at 3:30 PM at the registered office (Plot No 233-234-235, Sector-58, Faridabad, Haryana -121004) to consider the unaudited financial statements for the quarter and audited financial statements for the year ended March 31, 2026, along with the statutory auditors' report. The agenda also includes recommendation of dividend, if any, for FY 2025-26. The trading window for directors, designated persons, and their relatives remains closed from March 26, 2026, to May 31, 2026.
- · BSE Script Code: 522251, ISIN: INE627F01011
- · Filing reference: Pursuant to Reg 29(1)(a), Reg 29(1)(e) and Reg 30 of SEBI (LODR) Regulations, 2015
- · Previous intimation letter dated March 26, 2026
13-05-2026
Manomay Tex India Limited has informed that a Board of Directors meeting is scheduled for May 22, 2026, at its registered office in Bhilwara, Rajasthan, to consider and approve the Standalone Audited Financial Results for the quarter and year ended March 31, 2026, and to record the Auditors’ Report. The trading window for dealing in the company's securities remains closed for directors, officers, designated employees, and connected persons until May 24, 2026, in compliance with the Code of Conduct for prevention of insider trading. No financial metrics are disclosed in this intimation.
- · BSE Scrip Code: 540396; BSE Scrip ID: MTIL; NSE Company ID: MANOMAY; ISIN: INE784W01015
- · Meeting venue: 32, Heera Panna Market, Pur Road, Bhilwara - 311001 (Rajasthan), India
- · Compliance: Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
13-05-2026
Life Insurance Corporation of India has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to recommend a final dividend, if any, for the financial year ended March 31, 2026. The trading window for insiders remains closed from April 1, 2026, until 48 hours after the board meeting, i.e., until May 23, 2026, pursuant to SEBI regulations.
- · Scrip Code: BSE 543526, NSE LICI
- · Intimation reference: LIC/SE/2026-27/25
- · Website: www.licindia.in
13-05-2026
GlaxoSmithKline Pharmaceuticals Limited reported consolidated FY26 revenue from operations of ₹382167 Lakhs, up 2% YoY from ₹374921 Lakhs, though Q4 FY26 revenue declined 4% QoQ to ₹99530 Lakhs from ₹104126 Lakhs. Net profit for FY26 rose 12% YoY to ₹103598 Lakhs from ₹92758 Lakhs, aided by ₹2062 Lakhs exceptional items credit, while Q4 profit grew 6% YoY to ₹27786 Lakhs. The Board recommended a final dividend of Rs.57 per equity share (face value Rs.10) subject to approval at the 101st AGM on June 30, 2026, with record date May 29, 2026.
- · Record date for dividend: Friday, May 29, 2026.
- · 101st AGM date: Tuesday, June 30, 2026 via Video Conferencing/Other Audio Visual Means.
- · Dividend payment on/after July 1, 2026 if approved.
- · Company confirms non-applicability as Large Corporate: no debt securities, no long-term borrowings > Rs. 1,000 Crores, no credit ratings.
- · Exceptional items FY26: Rs.264 lakhs (surplus residential properties) + Rs.1798 lakhs (non-operational land).
- · Labour Codes impact: Rs.1182 lakhs increase in employee benefits expense FY26.
- · Total equity FY26: ₹226742 Lakhs (up from ₹195131 Lakhs FY25).
- · Paid-up equity share capital: 16941 Lakhs (face value Rs.10).
13-05-2026
NBCC (India) Limited has scheduled a Board of Directors meeting on May 25, 2026, to consider the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026 (FY 2025-26). The meeting will also address the recommendation of final dividend, if any, subject to shareholder approval at the ensuing Annual General Meeting. Pursuant to regulations, the trading window for insiders is closed from April 1, 2026, until 48 hours after the financial results declaration.
- · Pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015.
- · Information available on company website: nbccindia.in/webEnglish/BoardMeetingNotices.
- · NSE Symbol: NBCC/EQ; BSE Scrip code: 534309.
13-05-2026
Marico Limited has disclosed a postal ballot notice under Regulation 30 of SEBI Listing Regulations, seeking shareholder approval via special resolution for the appointment of Mr. Girish Paranjpe (DIN: 02172725) as an Independent Director for a 5-year term from June 1, 2026, to May 31, 2031. The Board appointed him as Additional Director effective June 1, 2026, following Nomination and Remuneration Committee recommendation. Remote e-voting opens May 15, 2026 (9:00 a.m. IST) and closes June 13, 2026 (5:00 p.m. IST), with results by June 16, 2026.
- · Cut-off date for e-voting eligibility: Friday, May 8, 2026
- · Board meeting approving appointment: May 5, 2026
- · Filing date: May 13, 2026
- · E-voting facility provider: Central Depository Services (India) Limited (CDSL)
13-05-2026
Standard Capital Markets Ltd. cancelled its rescheduled Board of Directors meeting, originally set for May 9, 2026, and moved to May 13, 2026, due to ongoing statutory audit activities engaging senior management. The agenda items will be consolidated and deferred to a forthcoming Board meeting, with details to be intimated separately in compliance with SEBI regulations.
- · Scrip Code: 511700
- · ISIN: INE625D01028
- · CIN: L74899DL1987PLC027057
13-05-2026
VLS Finance Limited has rescheduled its Board Meeting, originally set for May 18, 2026, to consider the Audited Financial Results for the financial year ended March 31, 2026, and to recommend dividend (if any), to May 26, 2026, due to unavoidable circumstances. The Trading Window for concerned persons remains closed until May 28, 2025, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015, following the earlier intimation on March 27, 2026.
- · BSE Scrip Code: 511333
- · NSE Scrip Code: VLSFJNANCE
- · CSE Scrip Code: 032019
- · Original intimation dated May 11, 2026
13-05-2026
Datamatics Global Services Limited announced that a Board of Directors meeting is scheduled for May 21, 2026, to approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, and to recommend dividend, if any, on equity shares. The trading window for dealing in the company's securities remains closed from April 1, 2026, until 48 hours after the declaration of the financial results, in compliance with SEBI (LODR) Regulations, 2015.
- · BSE Security Code: 532528
- · NSE Symbol: DATAMATICS
- · Regulation cited: SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 29(1)
- · Trading window closure start: April 01, 2026
- · Company CIN: L72200MH1987PLC045205
13-05-2026
Antariksh Industries Limited intimated the Bombay Stock Exchange that a Board of Directors meeting will be held on May 18, 2026, to approve the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026, and to recommend a final dividend, if any, subject to shareholder approval. The trading window for company equity shares has been closed for designated persons from April 1, 2026, until 48 hours after the public announcement of the board meeting outcomes, in compliance with SEBI (Prohibition of Insider Trading) Regulations.
- · Security Code: 501270
- · DIN: 11308356
- · Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- · Trading Window closure effective from Wednesday, April 01, 2026
13-05-2026
Banswara Syntex Limited has informed stock exchanges that a Board of Directors meeting is scheduled for May 19, 2026, to consider and approve the Audited Financial Results (standalone and consolidated) for the fourth quarter and financial year ended March 31, 2026, and to recommend dividend, if any, on equity shares. The trading window for directors, key managerial personnel, designated persons, and connected persons will reopen 48 hours after the declaration of these results, on May 22, 2026.
- · Scrip Code: 503722 (BSE), Symbol: BANSWRAS (NSE)
- · Meeting venue: 4th Floor, Gopal Bhawan, 199, Princess Street, Mumbai – 400 002
- · Reference: BSL/SEC/2026-27/05
13-05-2026
Archit Organosys Limited has notified BSE Limited that its Board of Directors will meet on May 16, 2026, to approve the audited financial results for the quarter and year ended March 31, 2026, and to recommend a final dividend subject to shareholder approval at the ensuing Annual General Meeting. In compliance with SEBI regulations, the trading window for promoters, directors, senior managerial personnel, their immediate relatives, and connected persons has been closed from April 1, 2026, and will reopen 48 hours after the results become publicly available.
- · BSE Scrip Code: 524640
- · DIN: 00038972 (Kandarp Amin)
- · Company address: Survey No. 228/A, Paiki 7, Paiki 2, Village - Narmad, Bhavnagar-364313, Gujarat, India
13-05-2026
JSL Industries Limited has intimated BSE Limited about its 60th Annual General Meeting (AGM) scheduled for Tuesday, July 7, 2026, at 11:00 a.m. IST via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The cut-off date for determining eligible members to attend and vote is June 29, 2026. The meeting complies with the Companies Act, 2013, and SEBI Listing Obligations and Disclosure Requirements.
- · Scrip Code: 504080
- · Company CIN: L31100GJ1966PLC001397
- · Contact: Village Mogar, Tal. & Dist. Anand, Gujarat; Phone: 02692-280224; Email: jsl@jslmogar.com; Website: www.jslmogar.com
13-05-2026
National Oxygen Ltd informed BSE on May 13, 2026, about newspaper advertisements published for the dispatch of the Extra-Ordinary General Meeting notice dated April 29, 2026, in compliance with Companies Act, 2013 and SEBI LODR Regulations. Advertisements appeared in Makkal Kural (Tamil) and Trinity Mirror (English). No financial performance metrics or changes reported in this procedural disclosure.
- · EGM notice dated 29.04.2026
- · Newspapers: Makkal Kural (Tamil), Trinity Mirror (English)
- · Registered office: S-1, 2nd Floor, Alsa Mall, New No.4 Old No.149, Montieth Road, Egmore, Chennai - 600 008
- · CIN: L24111TN1974PLC006819
- · Scrip Code: BSE: 507813
13-05-2026
Zydus Lifesciences Limited has provided prior intimation that its Board of Directors meeting, scheduled for May 19, 2026, will consider a proposal for the buyback of fully paid-up equity shares, in compliance with the Companies Act, 2013, SEBI Buy-back Regulations, 2018, and other applicable laws. This follows an earlier intimation dated May 8, 2026. The trading window for Directors and Designated Persons remains closed until May 21, 2026, reopening on May 22, 2026.
- · Scrip Code: 532321 (BSE), Symbol: ZYDUSLIFE (NSE)
- · References Regulation 29 of SEBI (LODR) Regulations, 2015
13-05-2026
A-1 Limited (formerly A-1 Acid Limited) revised its audited standalone financial results for the quarter and FY26 ended March 31, 2026, due to a typographical error in the total sales figure for the year. Revenue from operations grew modestly 3.4% YoY to ₹34,290.92 L, with strong Q4 growth of 32.6% YoY to ₹14,526.55 L, while profit after tax surged 64.1% YoY to ₹599.21 L supported by lower transport expenses (down 20.2% YoY to ₹1,706.49 L) and depreciation (down 20.2% to ₹286.60 L). However, other income slightly declined to ₹45.33 L from ₹48.08 L YoY.
- · Unqualified (unmodified) audit opinion issued on May 12, 2026.
- · Share of profit from Partnership Firm: Q4 FY25 loss ₹6.65 Lakh; FY25 loss ₹29.30 Lakh.
- · Major fire at registered office on April 12, 2025; adequately insured with net loss ₹2.41 Lakh.
- · Paid up equity share capital increased to ₹4,600.00 L from ₹1,150.00 L (face value INR 1 each).
- · Earnings Per Share (Basic & Diluted): FY26 ₹0.13; FY25 ₹0.08.
13-05-2026
Swadeshi Polytex Limited announced a Board Meeting scheduled for May 22, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026, the Director’s Report for FY 2025-26, and matters related to convening the Annual General Meeting. The trading window for designated persons and their immediate relatives has been closed since April 1, 2026, until 48 hours after the declaration of the audited financial results.
- · Scrip Code: 503816
- · CIN: L25209UP1970PLC003320
- · Regd Office: KJ-77, J-Block, Kavi Nagar, Ghaziabad-201002 (U.P.)
13-05-2026
Velox Shipping and Logistics Limited (formerly Velox Industries Limited) has intimated BSE of a Board meeting scheduled for May 16, 2026, to approve the allotment of 2,83,33,333 fully convertible share warrants on a preferential basis to non-promoter category allottees at an issue price of Rs. 12/- per warrant. The upfront subscription price is Rs. 3/- per warrant (25% of issue price), aggregating Rs. 8,49,99,999/-. The allotment follows prior approvals from shareholders and the stock exchange.
- · Board meeting pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015
- · BSE Scrip Code: 506178
- · CIN: L52242MH1983PLC029364
13-05-2026
Asian Energy Services Limited has notified that a Board of Directors meeting will be held on May 19, 2026, to consider and approve the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2026. The board will also consider recommending a final dividend on equity shares for the year, subject to shareholder approval at the Annual General Meeting. The trading window for insiders remains closed from April 1, 2026, until 48 hours after the financial results announcement.
- · BSE Scrip Code: 530355
- · Trading Symbol: ASIANENE
- · CIN: L23200MH1992PLC318353
- · Trading window closure period: 1st April 2026 to 48 hours after announcement on 19th May 2026
13-05-2026
The Board of Directors of Texmaco Infrastructure & Holdings Limited, at its meeting on May 13, 2026, approved the Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2026, accompanied by an unmodified Auditor's Report. The Board also recommended a dividend of 15% (₹0.15 per fully paid-up equity share of ₹1 each) for FY 2025-26, subject to shareholder approval at the ensuing AGM, with payment within 30 days of AGM approval.
- · Board meeting commenced at 1:30 p.m. and concluded at 3:45 p.m. on May 13, 2026
- · Stock symbol: TEXINFRA; Scrip Code: 505400
- · Auditor's Report issued with unmodified opinion on Standalone and Consolidated Financial Results
13-05-2026
The Board of Directors of Black Rose Industries Ltd approved the Standalone and Consolidated Audited Financial Statements for the quarter and FY ended March 31, 2026, with an unmodified opinion from Statutory Auditors M/s. M M Nissim & Co LLP. They recommended a final dividend of ₹1.25 per equity share (125% on paid-up share capital) subject to shareholder approval at the AGM, alongside appointing Cost Auditors, Internal Auditors, a new Company Secretary, and re-appointing/re-designating key executives. No negative financial indicators or audit qualifications were noted.
- · Audited financials prepared under Ind AS for quarter and FY ended March 31, 2026.
- · Re-appointment of Ambarish Daga effective July 25, 2026 for 3 years; Shruti Jatia effective September 2, 2026 for 3 years (both subject to postal ballot).
- · Redesignation of Ambarish Daga from Joint CFO and Investor Relations Officer to Investor Relations Officer.
- · Cost Auditor and Internal Auditor appointments for FY 2026-27 effective May 13, 2026.
- · Board meeting held May 13, 2026 from 11:30 a.m. to 3:50 p.m.
13-05-2026
Syncom Formulations (India) Limited has informed the stock exchanges that its Board of Directors will meet on Friday, May 22, 2026, at 3:00 p.m. at the Corporate Office in Indore to consider and approve the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2026. The agenda also includes taking on record the auditors' report and audited financial statements, including balance sheet, profit and loss statement, cash flows, and changes in equity. The company is filing this announcement pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulations, 2015.
- · Corporate Office location: 207, Saket Nagar, Near Saket Club, Indore - 452018 (M.P.).
- · Announcement digitally signed by Vaishali Agrawal on May 13, 2026.
- · XBRL filing to be hosted on BSE/NSE websites and company website www.sfil.in.
13-05-2026
Gennex Laboratories Ltd conducted an electronic Extraordinary General Meeting (EGM) on May 12, 2026, where the special resolution for regularizing Ms. Khushbu Kachhawa (DIN: 10872432) as a Non-Executive Independent Woman Director was approved with overwhelming majority (99.9997% votes in favor, only 0.0003% against). Total votes polled represented 12.8324% of 242947674 outstanding shares, with Promoter and Promoter Group achieving 100% approval on 54.1620% turnout of their 57405624 shares, while Public Non-Institutions had 99.8966% approval on minimal 0.0453% turnout. The scrutinizer confirmed all resolutions passed as per SEBI Regulation 44.
- · EGM held via VC/OAVM on May 12, 2026 at 12:30 Hrs (IST); cut-off date May 1, 2026
- · Remote e-voting open from May 8, 2026 9:00 AM to May 11, 2026 5:00 PM
- · Event ID: 139155; BSE Security ID: GENNEX, Script Codes: 531739, 890171, 26178
- · No invalid votes reported
- · Notice issued April 16, 2026; sent to 80047 members on April 20, 2026
13-05-2026
Jay Ushin Limited disclosed to BSE, pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, that two shareholders reported loss of share certificates and requested issuance of duplicates. The affected folios are MOOOl13 (MURTAZA BHAI, Certificate No. 3985, 100 shares, Distinctive Nos. 2073001-2073100) and SOO1459 (SAIFUDDINBHAI SK ABBASBHAI, Certificate No. 8180, 100 shares, Distinctive Nos. 2492501-2492600). This is a routine governance disclosure with no financial impact.
- · Certificate No. 3985: Distinctive Nos. 2073001 - 2073100
- · Certificate No. 8180: Distinctive Nos. 2492501 - 2492600
- · Filing Date: May 13, 2026
13-05-2026
Yashraj Containeurs Ltd., currently under Corporate Insolvency Resolution Process (CIRP), has postponed its RP Committee Meeting from May 15, 2026, to May 25, 2026, with no changes to the agenda items. The Trading Window for dealing in the company's shares remains closed until 48 hours after the announcement of the Audited financial results for the quarter and year ended March 31, 2026, per SEBI (Prohibition of Insider Trading) Regulations, 2015.
- · Scrip Code: 530063
- · CIN: L28120MH1993PLC073160
- · Resolution Professional Registration No: IBBI/IPA-003/IP-N00062/2017-2018/10548
13-05-2026
The Board of Directors of Shelter Infra Projects Limited (formerly CCAI Limited) held a meeting on May 13, 2025, from 1:00 P.M. to 4:00 P.M., approving the reconstitution of the Internal Complaints Committee in compliance with applicable provisions. The Board also noted recommendations, observations, and proposals from the Audit Committee meeting on May 13, 2026, related to compliance status, accounting policies, audit observations, and other matters. No financial or operational impacts were disclosed.
- · Scrip Code: BSE: 526839; CSE: 13077
- · DIN: 06742937
- · Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
- · Registered Office: Eternity, DN 1, Sector V, Saltlake City, Kolkata - 700 091
13-05-2026
The Board of Crompton Greaves Consumer Electricals Limited approved the audited standalone and consolidated financial results for the quarter and FY ended March 31, 2026, which reflect a consolidated net loss per the auditor's unmodified opinion. The Board recommended a dividend of ₹3 per equity share (150% of ₹2 face value), subject to AGM approval on August 07, 2026 (record date July 24, 2026), alongside re-appointments of statutory, cost, internal, and tax auditors, and amendments to several governance policies. No specific financial performance metrics like revenue or profit figures were disclosed in the filing.
- · 12th AGM scheduled for Friday, August 07, 2026, at 3:30 PM via video-conferencing, deemed at Registered Office in Mumbai.
- · Statutory Auditors MSKA & Associates LLP re-appointed for second 5-year term from conclusion of 12th AGM to 17th AGM.
- · Cost Auditors remuneration for FY 2026-27 subject to 12th AGM approval.
- · Board meeting held on May 13, 2026, from 10:00 A.M. to 03:50 P.M.
Get daily alerts with 12 investment signals, 9 risk alerts, 10 opportunities and full AI analysis of all 50 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Corporate Governance MCA ROC Filings
🇮🇳 More from India
View all →May 28, 2026
India Pre-Market Regulatory Roundup — May 28, 2026
India Pre-Market Regulatory Roundup
May 28, 2026
India Quarterly Results BSE NSE Announcements — May 28, 2026
India Quarterly Results BSE NSE Announcements
May 28, 2026
India Upcoming Corporate Actions BSE NSE — May 28, 2026
India Upcoming Corporate Actions BSE NSE
May 27, 2026
India Pre-Market Regulatory Roundup — May 27, 2026
India Pre-Market Regulatory Roundup